Effects of vitamin D supplementation on metabolic parameters in women with polycystic ovary syndrome: a randomized controlled trial.

What Was Tested

Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.

The aim of this study was to explore the effects of vitamin D supplementation on metabolic parameters in women with polycystic ovary syndrome (PCOS).

Who Took Part

According to the abstract, 60 women were involved.

PubMed indexes the participants as young adults and adults, women only.

A total of 60 PCOS women with vitamin D deficiency or insufficiency were enrolled in this randomized controlled trial.

The observational parameters were measured at baseline and after treatment, including body mass index (BMI), waist to hip ratio (WHR), oral glucose tolerance test (OGTT) and insulin release test, and lipid metabolism parameters.

How the Study Was Run

In design terms this was a randomized study.

The women were allocated by chance, so the Vitamin D, K2, Magnesium and Zinc group and the comparison group should start out alike.

What Was Measured

The subject headings attached to it are Polycystic Ovary Syndrome, Vitamin D, Dietary Supplements, Insulin Resistance, Body Mass Index, Insulin and Waist-Hip Ratio.

The authors tagged it with the keywords Metabolic diseases, Obesity and Vitamin D deficiency.

What This Means in Plain Language

The paper is a randomized study of Vitamin D, K2, Magnesium and Zinc in 60 women.

The abstract goes on to report its results in about 6 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2024 (Journal of ovarian research), a journal based in England.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.